SENSEX NIFTY
Nov 21, 2012, 05.04 PM IST | Source: CNBC-TV18

Cipla eyes South Africa with plans for Cipla Medpro stake

S Radhakrishnan, ED, Cipla explains to CNBC-TV18 that the company is in discussions to acquire a 51 percent stake in Cipla Medpro, South Africa for a consideration of USD 220 million. The acquisition also offers a stake in Cipla Medpro business in South Africa.

The acquisition also allows us a stake in Cipla Medpro’s business in South Africa

S Radhakrishnan

ED

Cipla

S Radhakrishnan, ED, Cipla explains to CNBC-TV18 that the company is in discussions to acquire a 51 percent stake in Cipla Medpro, South Africa for a consideration of USD 220 million. The acquisition also offers a stake in Cipla Medpro business in South Africa.

Below is an edited transcript of the interview on CNBC-TV18

Q: Can you explain the reason for interest in the acquisition and what it entails in terms of financial outlay?

A: To clarify, we are in preliminary discussions and I have made an indicative proposal of acquiring approximately a 51 percent equity stake in Cipla Medpro South Africa and the total outlay for the acquisition of 51 percent will be about USD 220 million. Cipla Medpro substantially procures and markets our products and logically, it is good to now integrate with our frontend and that is why we are proposing to make this acquisition.

Q: What is your current stake in Medpro?

A: We do not have any stake as of now. We supply our products to them which they market.

Q: What is the logic behind this USD 220 million outlay? What would it give you access to in terms of the kind of revenues that you have in South Africa today?

A: We supply products to them and they market the Cipla brand in South Africa. So this really gives us a stake in our own brands in South Africa and the company is worth over USD 200 million. The acquisition also allows us a stake in Cipla Medpro’s business in South Africa.

Q: Can breakdown the financials of the South African business?

A: Roughly, this company is a over-USD 200 million company and posted a bottom-line of USD 40 million last year.

Q: Would the entire USD 220 million be financed from accruals?

A: Yes, it would be financed through accruals.

Cipla stock price

On August 01, 2014, at 11:41 hrs Cipla was quoting at Rs 455.05, down Rs 1.25, or 0.27 percent. The 52-week high of the share was Rs 462.65 and the 52-week low was Rs 366.70.


The company's trailing 12-month (TTM) EPS was at Rs 17.29 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 26.32. The latest book value of the company is Rs 127.76 per share. At current value, the price-to-book value of the company is 3.56.

READ MORE ON  Cipla Medpro, Cipla , South Africa
Set email alert for

ADS BY GOOGLE

video of the day

No definite plans for merger of PSU banks: Banking Secy

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.